Evidence map›Paper›PMID 23446184›Full record

ArticleJournal of breath research2013

A mobile instrumentation platform to distinguish airway disorders.

Michael Schivo, Felicia Seichter, Alexander A Aksenov, Alberto Pasamontes, Daniel J Peirano, Boris Mizaikoff, Nicholas J Kenyon, Cristina E Davis

Open access · greenAbstract read
In one paragraph

Article in Journal of breath research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Viruses and non-allergen environmental triggers in asthma.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2019
    Review
  5. Article
  6. Modular and reconfigurable gas chromatography / differential mobility spectrometry (GC/DMS) package for detection of volatile organic compounds (VOCs).International journal for ion mobility spectrometry : official publication of the International Society for Ion Mobility Spectrometry · 2018
    Article
  7. Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2017
    Review
  8. Article
  9. Supervised Semi-Automated Data Analysis Software for Gas Chromatography / Differential Mobility Spectrometry (GC/DMS) Metabolomics Applications.International journal for ion mobility spectrometry : official publication of the International Society for Ion Mobility Spectrometry · 2016
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Michael SchivoDivision of Pulmonary, Critical Care, and Sleep Medicine, Center for Comparative Respiratory Biology and Medicine, University of California, Davis, CA 95616, USA.
Felicia Seichter
Alexander A Aksenov
Alberto Pasamontes
Daniel J Peirano
Boris Mizaikoff
Nicholas J Kenyon
Cristina E Davis
University of California, Davis · USUniversität Ulm · DE

Funding

UC DAVIS CLINICAL AND TRANSLATIONAL SCIENCE CENTER: BPCAUL1RR024146 · NCRR · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2006 to 2011
$27.0M
UC Davis Clinical and Translational Science CenterUL1TR000002 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$12.2M
TRAINING IN COMPARATIVE LUNG BIOLOGY AND MEDICINET32HL007013 · NHLBI · UNIVERSITY OF CALIFORNIA DAVIS · PI Elena Goncharova, Nicholas J. KENYON · 1985 to 2026
$10.1M
ENVIRONMENTAL TOXICOLOGYT32ES007059 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura S Van Winkle · 1985 to 2026
$7.9M
UC Davis Clinical and Translational Science CenterKL2TR000134 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$3.1M
L-arginine as a therapy in severe asthmaR01HL105573 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J. · 2012 to 2016
$1.9M
NCATS NIH HHS K12 8KL2TR000134-07NCATS NIH HHS KL2 TR000134NCATS NIH HHS UL1 TR000002NCRR NIH HHS UL1 RR024146NHLBI NIH HHS HL 105573NHLBI NIH HHS R01 HL105573NHLBI NIH HHS T32 HL007013NHLBI NIH HHS T32-HL007013NIEHS NIH HHS T32 ES007059NIEHS NIH HHS T32-ES007059
6 · The paper itself

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are distinct but clinically overlapping airway disorders which often create diagnostic and therapeutic dilemmas. Current strategies to discriminate these diseases are limited by insensitivity and poor performance due to biologic variability. We tested the hypothesis that a gas chromatograph/differential mobility spectrometer (GC/DMS) sensor could distinguish between clinically well-defined groups with airway disorders based on the volatile organic compounds (VOCs) obtained from exhaled breath. After comparing VOC profiles obtained from 13 asthma, 5 COPD and 13 healthy control subjects, we found that VOC profiles distinguished asthma from healthy controls and also a subgroup of asthmatics taking the drug omalizumab from healthy controls. The VOC profiles could not distinguish between COPD and any of the other groups. Our results show a potential application of the GC/DMS for non-invasive and bedside diagnostics of asthma and asthma therapy monitoring. Future studies will focus on larger sample sizes and patient cohorts.

Indexed as

AdultAgedAnti-Asthmatic AgentsAntibodies, Anti-IdiotypicAntibodies, Monoclonal, HumanizedAsthmaBreath TestsCase-Control StudiesChromatography, GasCross-Sectional StudiesFeasibility StudiesFemaleHumansMaleMiddle AgedOmalizumabAnti-Asthmatic AgentsAntibodies, Anti-IdiotypicAntibodies, Monoclonal, HumanizedOmalizumabVolatile Organic Compounds

Identifiers

PMID23446184
PMCPMC3633523
OpenAlexW2017833082

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.